Abstract Colorectal cancer (CRC) chemotherapy remains clinically challenging due to the emergence of drug resistance, off-target toxicity, and suboptimal patient compliance, underscoring the need for innovative, patient-centric delivery systems specially designed for targeted CRC therapy
Differences between samples were assessed using independent two-tailed t-tests or analysis of variance (ANOVA)
It is found in human blood, saliva, and urine
Thus, given the particularities of the observed BPC 157 therapy effect [1,2,3,4,5,6,7,8,9,10,11,15,27,28,29,30,33,109,124,125], this final point, the equation between the exogenous effects and endogenous presence to verify endogenous presence and significance, can be a suggestive argument for the possible BPC 157/neurotransmitter relation
The frequency of glutathione IV therapy depends on individual health needs and goals
10.1071/FP06049 117 O'BrienJ